Current status and future prospects of noninvasive preimplantation genetic testing for aneuploidy
Preimplantation genetic testing for aneuploidy (PGT-A) aims to assist in the identification of euploid embryos generated using assisted reproductive technology, allowing them to be prioritized for transfer. The selection of euploid embryos should, theoretically, lead to a reduction in the risks of miscarriage, aneuploid conception, and implantation failure. Any strategy improving the likelihood that the embryo selected for transfer is viable should reduce the time required to achieve a pregnancy using assisted reproductive technology.
Source: fertstert.org
Current status and future prospects of noninvasive preimplantation genetic testing for aneuploidy
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment